Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zanger

Showing results (41-50 of 203) with videos related to

Pageof 21
Sort By:
Toxicology|January 28, 2012
Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolismAlice L Crane, Kathrin Klein, Ulrich M Zanger, et al.
Frontiers in Pharmacology|September 16, 2011
Pathway-Targeted Pharmacogenomics of CYP1A2 in Human LiverKathrin Klein, Stefan Winter, Miia Turpeinen, et al.
Toxicology Mechanisms and Methods|December 22, 2009
Impact of genetic polymorphism in relation to other factors on expression and function of human drug-metabolizing p450sUlrich M Zanger, Kathrin Klein, Tanja Richter, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 1992
3',5'-cyclic adenosine monophosphate-dependent transcription of the CYP11A (cholesterol side chain cleavage cytochrome P450) gene involves a DNA response element containing a putative binding site for transcription factor Sp1K Momoi, M R Waterman, E R Simpson, et al.
Bulletin of Environmental Contamination and Toxicology|April 1, 1997
Detection and induction of cytochrome P450IA (CYP 1A)-like proteins in Julus scandinavius (Diplopoda) and Oniscus asellus (Isopoda): a first analysisM Zanger, S Gräff, T Braunbeck, et al.
The Pharmacogenomics Journal|October 28, 2015
Gene copy number variation analysis reveals dosage-insensitive expression of CYP2E1R Tremmel, K Klein, S Winter, et al.
Biochemistry|July 26, 1988
Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in manU M Zanger, F Vilbois, J P Hardwick, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2015
Inflammation-associated microRNA-130b down-regulates cytochrome P450 activities and directly targets CYP2C9Jessica K Rieger, Sandra Reutter, Ute Hofmann, et al.
Current Microbiology|July 11, 2023
Understanding Viral Impacts in Soil Microbial Ecology Through the Persistence and Decay of Infectious BacteriophagesAlessandra G DiPietro, Shawn A Bryant, Matthew M Zanger, et al.
Molecular and Cellular Endocrinology|September 1, 1993
The sequence of the 5'-end of the rat CYP17 gene, the transcription initiation site and a comparison with the homologous genes of other speciesH R Fevold, J D Ivanovitch, U M Zanger, et al.
Pageof 21

Showing results (41-50 of 203) with videos related to

Sort By:
Pageof 21
Toxicology|January 28, 2012
Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolismAlice L Crane, Kathrin Klein, Ulrich M Zanger, et al.
Frontiers in Pharmacology|September 16, 2011
Pathway-Targeted Pharmacogenomics of CYP1A2 in Human LiverKathrin Klein, Stefan Winter, Miia Turpeinen, et al.
Toxicology Mechanisms and Methods|December 22, 2009
Impact of genetic polymorphism in relation to other factors on expression and function of human drug-metabolizing p450sUlrich M Zanger, Kathrin Klein, Tanja Richter, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 1992
3',5'-cyclic adenosine monophosphate-dependent transcription of the CYP11A (cholesterol side chain cleavage cytochrome P450) gene involves a DNA response element containing a putative binding site for transcription factor Sp1K Momoi, M R Waterman, E R Simpson, et al.
Bulletin of Environmental Contamination and Toxicology|April 1, 1997
Detection and induction of cytochrome P450IA (CYP 1A)-like proteins in Julus scandinavius (Diplopoda) and Oniscus asellus (Isopoda): a first analysisM Zanger, S Gräff, T Braunbeck, et al.
The Pharmacogenomics Journal|October 28, 2015
Gene copy number variation analysis reveals dosage-insensitive expression of CYP2E1R Tremmel, K Klein, S Winter, et al.
Biochemistry|July 26, 1988
Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in manU M Zanger, F Vilbois, J P Hardwick, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2015
Inflammation-associated microRNA-130b down-regulates cytochrome P450 activities and directly targets CYP2C9Jessica K Rieger, Sandra Reutter, Ute Hofmann, et al.
Current Microbiology|July 11, 2023
Understanding Viral Impacts in Soil Microbial Ecology Through the Persistence and Decay of Infectious BacteriophagesAlessandra G DiPietro, Shawn A Bryant, Matthew M Zanger, et al.
Molecular and Cellular Endocrinology|September 1, 1993
The sequence of the 5'-end of the rat CYP17 gene, the transcription initiation site and a comparison with the homologous genes of other speciesH R Fevold, J D Ivanovitch, U M Zanger, et al.
Pageof 21